glp-1 not injected Agonists: A Comprehensive Overview Why is my GLP-1 medication
Description
[DOI] [PubMed] [Google Scholar] 20.Klok MD, Jakobsdottir S, Drent ML
Contact your GP for routine assessment if: Urinary frequency significantly disrupts daily activities or sleep You notice persistent changes in urine colour, smell, or appearance Urinary symptoms persist beyond the initial adjustment period (typically 48 weeks) You have concerns about medication side effects or diabetes control Your healthcare provider can perform appropriate investigations, including urinalysis, renal function tests, and HbA1c measurement, to determine the underlying cause of urinary changes and adjust your treatment plan accordingly
Interleukin inhibitors : Ustekinumab (Stelara) targets IL-12 and IL-23 pathways, while risankizumab (Skyrizi) specifically inhibits IL-23
Tirzepatide: a systematic update
Endocrinology 160 , 29592968 (2019)
